Predicting cirrhosis risk based on the level of circulating hepatitis B viral load.
暂无分享,去创建一个
Chien-Jen Chen | Hwai I. Yang | C. Jen | S. You | U. Iloeje | Chien-Jen Chen | San-Lin You | Hwai-I Yang | Jun Su | Uchenna H Iloeje | Chin-Lan Jen | Jun Su
[1] Y. Liaw,et al. Ultrasonographic changes of early liver cirrhosis in chronic hepatitis B: A longitudinal study , 1993, Journal of clinical ultrasound : JCU.
[2] F. Chisari,et al. Immune Pathogenesis of Hepatocellular Carcinoma , 1998, The Journal of experimental medicine.
[3] Shinn-Jang Hwang,et al. Factors predictive of liver cirrhosis in patients with chronic hepatitis B: a multivariate analysis in a longitudinal study , 2000, European journal of gastroenterology & hepatology.
[4] G. Fattovich,et al. Long‐term outcome of hepatitis B e antigen–positive patients with compensated cirrhosis treated with interferon alfa , 1997, Hepatology.
[5] Chien-Jen Chen,et al. Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men. , 2005, Journal of the National Cancer Institute.
[6] B. McMahon,et al. Serologic and Clinical Outcomes of 1536 Alaska Natives Chronically Infected with Hepatitis B Virus , 2001, Annals of Internal Medicine.
[7] R. Michael. B Virus Infection , 1966 .
[8] R. Beasley. Hepatitis B virus. The major etiology of hepatocellular carcinoma , 1988, Cancer.
[9] C. Chu,et al. Age‐specific prevalence and significance of hepatitis B e antigen and antibody in chronic hepatitis B virus infection in taiwan: A comparison among asymptomatic carriers, Chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma , 1984, Journal of medical virology.
[10] A. García-Sánchez,et al. Development of cirrhosis after chronic type B hepatitis: a clinicopathologic and follow-up study of 46 HBeAg-positive asymptomatic patients. , 1991, The American journal of gastroenterology.
[11] Z. Gao,et al. [Relationship between HBV DNA serum level and acute exacerbation of the disease in chronic hepatitis B patients]. , 1999, Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology.
[12] Ding‐Shinn Chen,et al. Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B. , 2000, Gastroenterology.
[13] G. Fattovich,et al. Natural history and prognostic factors for chronic hepatitis type B. , 1991, Gut.
[14] N. Sanford,et al. Is ultrasonography useful in the assessment of diffuse parenchymal liver disease? , 1985, Gastroenterology.
[15] V. Savarino,et al. Is hepatic ultrasonography a valid alternative tool to liver biopsy? report on 507 cases studied with both techniques , 1988, Digestive Diseases and Sciences.
[16] Pietro Andreone,et al. Clinical outcome of HBeAg‐negative chronic hepatitis B in relation to virological response to lamivudine , 2004, Hepatology.
[17] E. Christensen,et al. Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients , 2002, American Journal of Gastroenterology.
[18] T. Kurimura,et al. Risk of liver cirrhosis and hepatocellular carcinoma in subjects with hepatitis B and delta virus infection: A study from Kure, Japan , 1993, Journal of gastroenterology and hepatology.
[19] Ding‐Shinn Chen,et al. Genotypes and Clinical Phenotypes of Hepatitis B Virus in Patients with Chronic Hepatitis B Virus Infection , 2002, Journal of Clinical Microbiology.
[20] M. Bernardi,et al. High risk of hepatocellular carcinoma in anti‐HBe positive liver cirrhosis patients developing lamivudine resistance , 2004, Journal of viral hepatitis.
[21] R. D. de Man,et al. Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver. , 1992, Gastroenterology.
[22] Zhan Weiwe,et al. Value of Doppler ultrasound parameters of portal vein and hepatic artery in the diagnosis of cirrhosis and portal hypertension , 2006 .
[23] H. Ishibashi,et al. Ultrasound evaluation of the fibrosis stage in chronic liver disease by the simultaneous use of low and high frequency probes. , 2005, The British journal of radiology.
[24] B. McMahon,et al. Chronic hepatitis B , 2001, Hepatology.
[25] B. McMahon,et al. Hepatitis B-related sequelae. Prospective study in 1400 hepatitis B surface antigen-positive Alaska native carriers. , 1990, Archives of internal medicine.
[26] K. Koike,et al. Serology of acute exacerbation in chronic hepatitis B virus infection. , 1993, Gastroenterology.
[27] E. Christensen,et al. Occurrence of hepatocellular carcinoma and decompensation in western european patients with cirrhosis type B , 1995, Hepatology.
[28] C. Chu,et al. Long‐term beneficial effect of interferon therapy in patients with chronic hepatitis B virus infection , 1999, Hepatology.
[29] B. McMahon,et al. Chronic hepatitis B , 2001, Hepatology.
[30] A. Lok,et al. Management of hepatitis B: 2000--summary of a workshop. , 2001, Gastroenterology.
[31] D. Häussinger,et al. Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B. , 1996, The New England journal of medicine.
[32] E. Christensen,et al. Survival and prognostic factors in 366 patients with compensated cirrhosis type B: a multicenter study , 1994 .
[33] C. Chu,et al. Changes of serum hepatitis B virus DNA in two types of clinical events preceding spontaneous hepatitis B e antigen seroconversion in chronic type B hepatitis , 1987, Hepatology.
[34] H. Chiou,et al. Long‐term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B , 2002, Hepatology.
[35] Wayne Nelson. Theory and Applications of Hazard Plotting for Censored Failure Data , 2000, Technometrics.
[36] N. Breslow,et al. A Large Sample Study of the Life Table and Product Limit Estimates Under Random Censorship , 1974 .
[37] Ding‐Shinn Chen,et al. Hepatitis B Virus Infection , 2007 .
[38] C. J. Chen,et al. Prospective study of hepatocellular carcinoma and liver cirrhosis in asymptomatic chronic hepatitis B virus carriers. , 1997, American journal of epidemiology.
[39] O. Aalen. Nonparametric Inference for a Family of Counting Processes , 1978 .
[40] L. Bolondi,et al. What is the criterion for differentiating chronic hepatitis from compensated cirrhosis? A prospective study comparing ultrasonography and percutaneous liver biopsy. , 1997, Journal of hepatology.
[41] M. Yuen,et al. Natural history of chronic hepatitis B virus infection , 2000, Journal of gastroenterology and hepatology.
[42] B. McMahon,et al. Chronic hepatitis B: Update of recommendations , 2004, Hepatology.
[43] Oliver N Keene,et al. Lamivudine for patients with chronic hepatitis B and advanced liver disease. , 2004, The New England journal of medicine.
[44] Sheng-Nan Lu,et al. Correlation between ultrasonographic and pathologic diagnoses of hepatitis B and C virus-related cirrhosis , 2003, Journal of gastroenterology.
[45] C. Chu,et al. The development of cirrhosis in patients with chronic type B hepatitis: A prospective study , 1988, Hepatology.